제약 등급 락토스 썸네일

칠레 제약 등급 락토스 공급업체 및 가격 — 마켓 오버뷰 2026

상위 제품
유당
최종 업데이트
2026-07-16
서치 및 소싱 팀을 위한 핵심 요약
  • 칠레의 제약 등급 락토스 마켓 인텔리전스 페이지에는 프리미엄 공급업체 0개가 포함되어 있습니다.
  • 칠레에 대한 샘플 수출 거래 0건이 요약되어 있습니다.
  • 칠레의 제약 등급 락토스에 대해 수출 파트너 기업 0개와 수입 파트너 기업 0개가 매핑되어 있습니다.
  • 도매 샘플 항목: 0건; 산지가 샘플 항목: 0건.
  • 수출 파트너 국가 0개와 수입 파트너 국가 0개가 랭킹되어 있습니다.
  • 페이지 데이터 최종 업데이트일: 2026-07-16.

칠레의 제약 등급 락토스 수입 바이어 인텔리전스 및 가격 시그널: 바이어, 수요, 거래 파트너

칠레의 제약 등급 락토스에 대해 수입 파트너 기업 0개가 추적됩니다. 수출업체와 수입업체는 Supply Chain Intelligence 회사 프로필 및 분석을 활용해 바이어 수요, 파트너 밀도, 다운스트림 채널을 분석할 수 있습니다.
스캐터 포인트는 전체 거래 데이터셋의 100.0%에서 샘플링되었습니다.

제약 등급 락토스의 칠레 샘플 수입 거래 및 가격 기록

칠레의 제약 등급 락토스 샘플 수입 거래 5건은 가격 수준과 수요 측 거래 패턴 벤치마킹을 위한 날짜, 원산지, 무역 국가 맥락을 제공합니다.
칠레의 제약 등급 락토스 샘플 수입 거래 단가(일자별): 2025-11-06: 87.88 USD / kg, 2025-11-05: 3.50 USD / kg, 2025-11-03: 8.61 USD / kg, 2025-09-09: 6.76 USD / kg, 2025-09-09: 3.88 USD / kg.
일자신고 품목단가수출업체수입업체원산지 
2025-11-06LAC**** *********************** ** ********* ** ******* ******** * ***** ** **** *** **** ********* ************87.88 USD / kg (-) (-)-
2025-11-05LAC**** **************** **************** ****** ****** ****** *** ************** ******* ** ** ****************** ************ ******** ** ******* ** ***3.50 USD / kg (-) (-)-
2025-11-03LAC**** *************************** ** ********* ** ******* ******** * ***** ** ******* ***************8.61 USD / kg (-) (-)-
2025-09-09LAC**** ************************* ** ********* ** ******* ******** * ***** ** ******* ***************6.76 USD / kg (-) (-)-
2025-09-09LAC**** *********************** ** ********* ** ******* ******** * ***** ** **** *** **** ********* ************3.88 USD / kg (-) (-)-

Classification

Product TypeIngredient
Product FormPowder
Industry PositionPharmaceutical Excipient (Dairy-Derived Ingredient)

Market

Pharmaceutical-grade lactose in Chile is primarily an import-supplied excipient used by local drug-product manufacturers (notably solid oral dosage plants). Chile has a sizeable upstream dairy sector concentrated in the southern regions (Los Lagos and Los Ríos), but public sources reviewed do not evidence significant domestic production of pharmaceutical-grade lactose as a dedicated excipient stream. Market access is strongly shaped by Chile’s sanitary import controls for milk and dairy products (SAG), including establishment authorization/listing requirements for eligible exporters. For formulation use, buyers typically require compendial compliance documentation (e.g., USP–NF / Ph. Eur.) and traceable Certificates of Analysis from the excipient supplier.
Market RoleNet importer for pharmaceutical-grade lactose (pharmaceutical excipient market)
Domestic RoleInput excipient for domestic pharmaceutical manufacturing (solid oral dose) and related formulation activities

Specification

Physical Attributes
  • Controlled particle-size lactose grades are used to achieve flow and fill performance (e.g., crystalline/sieved grades for capsule filling and sachets).
Compositional Metrics
  • Buyer specifications commonly reference compendial identity/purity requirements aligned to pharmacopeias such as USP–NF and/or Ph. Eur. for lactose monohydrate / anhydrous lactose.
Grades
  • Pharmaceutical lactose grades may be differentiated by hydration state (monohydrate vs anhydrous) and particle-size profile (e.g., oral solid dose vs inhalation-oriented cuts), depending on the formulation route.
Packaging
  • Bulk excipient packaging commonly includes 25 kg multi-layer paper bags with a PE liner (supplier-dependent).

Supply Chain

Value Chain
  • Overseas dairy processing (whey separation) → lactose purification/crystallization/drying → excipient packaging → sea freight to Chile → SAG sanitary clearance (where applicable) + customs entry → importer warehousing → distribution to pharmaceutical manufacturing sites
Temperature
  • Ambient storage is typical; moisture control is critical to maintain powder flow and prevent caking during transit and warehousing.
Atmosphere Control
  • Keep packaging sealed and protected from humidity, especially for long ocean transit and coastal warehousing conditions.
Shelf Life
  • Shelf-life is supplier-declared; a major excipient supplier lists 36 months for a crystalline lactose monohydrate grade (product-specific).
Freight IntensityMedium
Transport ModeSea

Risks

Regulatory Compliance HighDairy-derived lactose shipments can be blocked or delayed if they fall under SAG dairy import controls and the exporting establishment (and, where applicable, raw-material sourcing) is not authorized/listed or required sanitary documentation/traceability is incomplete under SAG’s dairy import requirements framework.Before contracting, confirm whether the specific lactose grade/use-case is subject to SAG dairy controls; verify exporter establishment listing/eligibility, align certificates to SAG requirements, and pre-clear documentation with the Chilean importer/broker.
Quality Assurance MediumPharmaceutical-grade lactose must meet compendial and buyer specifications; gaps in CoA/compendial alignment (e.g., USP–NF / Ph. Eur. expectations) can prevent quality release at GMP manufacturing sites even if customs clearance succeeds.Lock the required pharmacopeia edition/spec in the supply agreement; require CoA + change-control notifications and perform incoming QC against agreed specifications.
Logistics MediumLong ocean transit to Chile increases exposure to delay and humidity-related caking/flow loss if packaging integrity or storage discipline is weak, which can disrupt downstream tableting/capsule operations.Use moisture-protective liners, container desiccants where appropriate, and controlled warehousing; validate packaging performance and handling SOPs with the distributor.
Sustainability
  • Animal welfare scrutiny in dairy supply chains (Chile’s SAG references alignment with international animal-welfare guidelines and cooperation frameworks).
  • Dairy farm welfare and health indicators (e.g., calf welfare) are an active research and assurance topic in Chile, relevant to upstream reputational risk for dairy-derived excipients.
Labor & Social
  • Labor conditions and labor relations in dairy processing plants in Los Lagos and Los Ríos have been formally studied by Chile’s Dirección del Trabajo (DT), indicating ongoing compliance and working-conditions focus in the sector.

FAQ

Can lactose (including pharmaceutical material) be subject to Chile’s SAG dairy import controls?Yes. Chile’s SAG sets sanitary requirements for importing milk and dairy products, and export guidance for Chile explicitly includes lactose and its derivatives (including as pharmaceutical material) within the dairy import framework; eligibility can depend on establishment authorization/listing and compliant sanitary documentation.
Where is Chile’s dairy production concentrated, relevant to upstream whey availability?Chile’s dairy herd and production base is concentrated in the southern regions, especially Los Lagos and Los Ríos, which ODEPA identifies as the main concentration area for dairy cattle and production units.
What specifications are typically expected for pharmaceutical-grade lactose used by Chilean manufacturers?Pharmaceutical buyers commonly expect compendial compliance (often USP–NF and/or Ph. Eur. for lactose monohydrate/anhydrous lactose), plus a traceable Certificate of Analysis and particle-size/flow characteristics appropriate to the intended dosage form (e.g., capsule filling or tableting).

제약 등급 락토스 연관 제품 카테고리

제약 등급 락토스의 상위 제품, 하위 제품, 파생 제품, 원재료 제품 마켓 페이지를 둘러보세요.
상위 제품: 유당
'쿠키 허용'을 클릭하면 통계 및 개인 선호도 산출을 위한 쿠키 제공에 동의하게 됩니다. 개인정보 보호정책에서 쿠키에 대한 자세한 내용을 확인할 수 있습니다.